Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group

被引：12

作者：

Collier, Anderson B., III ^{[1
]}

Krailo, Mark D. ^{[2
]}

Dang, Ha M. ^{[2
]}

DuBois, Steven G. ^{[3
,4
]}

Hawkins, Douglas S. ^{[5
]}

Bernstein, Mark L. ^{[6
]}

Bomgaars, Lisa R. ^{[7
]}

Reed, Damon R. ^{[8
,9
,10
]}

Gorlick, Richard G. ^{[11
]}

Janeway, Katherine A. ^{[3
,4
]}

机构：

[1] Univ Mississippi, Dept Pediat, Med Ctr, 2500 North Sate St, Jackson, MS 38219 USA

[2] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90007 USA

[3] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA

[4] Harvard Med Sch, Boston, MA 02115 USA

[5] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA

[6] Dalhousie Univ, IWK Hlth Ctr, Port Williams, NS, Canada

[7] Baylor Coll Med, Dept Pediat, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA

[8] Johns Hopkins All Childrens Hosp, Canc Ctr, St Petersburg, FL USA

[9] Johns Hopkins All Childrens Hosp, Blood Disorders Inst, St Petersburg, FL USA

[10] H Lee Moffitt Canc Ctr & Res Inst, Dept Individualized Canc Management, Tampa, FL USA

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

PEDIATRIC BLOOD & CANCER | 2021年 / 68卷 / 12期

关键词：

event-free survival; Ewing sarcoma; objective response; outcome; phase; 2; trials; relapsed; REFRACTORY SOLID TUMORS; II TRIAL; CHEMOTHERAPY; CRITERIA;

D O I：

10.1002/pbc.29333

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SevenChildren's Oncology Group phase 2 trials for patients with relapsed/progressive solid tumors were analyzed to estimate the event-free survival (EFS) for relapsed/progressive Ewing sarcoma. One hundred twenty-eight Ewing sarcoma patients were enrolled and 124 events occurred. The 6-month EFS was 12.7%, demonstrating the poor outcome of these patients. Only docetaxel achieved its protocol-specified radiographic response rate for activity; however, the EFS for docetaxel was similar to other agents, indicating that a higher radiographic response rate may not translate into superior disease control. This EFS benchmark could be utilized as an additional endpoint in trials for recurrent Ewing sarcoma.

引用

页数：5

共 50 条

[31] Comparative Evaluation of Local Control Strategies in Localized Ewing Sarcoma of Bone A Report From the Children's Oncology Group
DuBois, Steven G.
Krailo, Mark D.
Gebhardt, Mark C.
Donaldson, Sarah S.
Marcus, Karen J.
Dormans, John
Shamberger, Robert C.
Sailer, Scott
Nicholas, Richard W.
Healey, John H.
Tarbell, Nancy J.
Randall, R. Lor
Devidas, Meenakshi
Meyer, James S.
Granowetter, Linda
Womer, Richard B.
Bernstein, Mark
Marina, Neyssa
Grier, Holcombe E.
CANCER, 2015, 121 (03) : 467 - 475
[32] Local control in pelvic Ewing sarcoma: Analysis from INT-0091 - A report from the Children's Oncology Group
Yock, Torunn I.
Krailo, Mark
Fryer, Christopher J.
Donaldson, Sarah S.
Miser, James S.
Chen, Zhengjia
Bernstein, Mark
Laurie, Fran
Gebhardt, Mark C.
Grier, Holcombe E.
Tarbell, Nancy J.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3838 - 3843
[33] Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group
Elgarten, Caitlin W.
Thompson, Joel C.
Angiolillo, Anne
Chen, Zhiguo
Conway, Susan
Devidas, Meenakshi
Gupta, Sumit
Kairalla, John A.
McNeer, Jennifer L.
O'Brien, Maureen M.
Rabin, Karen R.
Rau, Rachel E.
Rheingold, Susan R.
Wang, Cindy
Wood, Charlotte
Raetz, Elizabeth A.
Loh, Mignon L.
Alexander, Sarah
Miller, Tamara P.
PEDIATRIC BLOOD & CANCER, 2022, 69 (11)
[34] Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials
Spunt, Sheri L.
Francotte, Nadine
De Salvo, Gian Luca
Chi, Yueh-Yun
Zanetti, Ilaria
Hayes-Jordan, Andrea
Kao, Simon C.
Orbach, Daniel
Brennan, Bernadette
Weiss, Aaron R.
van Noesel, Max M.
Million, Lynn
Alaggio, Rita
Parham, David M.
Kelsey, Anna
Randall, R. Lor
McCarville, M. Beth
Bisogno, Gianni
Hawkins, Douglas S.
Ferrari, Andrea
EUROPEAN JOURNAL OF CANCER, 2019, 112 : 98 - 106
[35] A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhab domyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group
Baruchel, Sylvain
Pappo, Alberto
Krailo, Mark
Baker, K. Scott
Wu, Bing
Villaluna, Doojduen
Lee-Scott, Michelle
Adamson, Peter C.
Blaney, Susan M.
EUROPEAN JOURNAL OF CANCER, 2012, 48 (04) : 579 - 585
[36] Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report
Leavey, Patrick J.
Laack, Nadia N.
Krailo, Mark D.
Buxton, Allen
Randall, R. Lor
DuBois, Steven G.
Reed, Damon R.
Grier, Holcombe E.
Hawkins, Douglas S.
Pawel, Bruce
Nadel, Helen
Womer, Richard B.
Letson, G. Douglas
Bernstein, Mark
Brown, Kenneth
Maciej, Alexis
Chuba, Paul
Ahmed, Atif A.
Indelicato, Daniel J.
Wang, Dian
Marina, Neyssa
Gorlick, Richard
Janeway, Katherine A.
Mascarenhas, Leo
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4029 - +
[37] Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group
DuBois, Steven G.
Krailo, Mark D.
Glade-Bender, Julia
Buxton, Allen
Laack, Nadia
Randall, R. Lor
Chen, Helen X.
Seibel, Nita L.
Boron, Matthew
Terezakis, Stephanie
Hill-Kayser, Christine
Hayes, Andrea
Reid, Joel M.
Teot, Lisa
Rakheja, Dinesh
Womer, Richard
Arndt, Carola
Lessnick, Stephen L.
Crompton, Brian D.
Kolb, E. Anders
Daldrup-Link, Heike
Eutsler, Eric
Reed, Damon R.
Janeway, Katherine A.
Gorlick, Richard G.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) : 2098 - +
[38] Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated with Radiation Therapy: A Report from the Children's Oncology Group
Ahmed, S. K.
Witten, B.
Harmsen, W. S.
Rose, P. S.
Krailo, M.
Marcus, K. J.
Randall, R. L.
Dubois, S. G.
Janeway, K. A.
Womer, R. B.
Granowetter, L.
Grier, H. E.
Gorlick, R. G.
Laack, N. N., II
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S122 - S122
[39] Regarding the Children's Oncology Group AEWS1031 Trial for Ewing Sarcoma
Wang, Ji-Gan
Wei, Qiu-Fen
Tang, Qu-Mei
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (13) : 1506 - +
[40] Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group
Ahmed, Safia K.
Witten, Brent G.
Harmsen, William S.
Rose, Peter S.
Krailo, Mark
Marcus, Karen J.
Randall, R. Lor
DuBois, Steven G.
Janeway, Katherine A.
Womer, Richard B.
Grier, Holcombe E.
Gorlick, Richard G.
Laack, Nadia N. I.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (02): : 337 - 346

← 1 2 3 4 5 →